Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hung Hung

Showing results (311-320 of 563) with videos related to

Pageof 57
Sort By:
Rheumatology International|April 14, 2009
IkBα promoter polymorphisms in patients with ankylosing spondylitisYu-Hung Hung, Tsan-Teng Ou, Chia-Hui Lin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 3, 2016
Liver stiffness-based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapyJing-Houng Wang, Yi-Hao Yen, Chih-Chien Yao, et al.
Journal of Hepatology|November 22, 2005
Comparison of sequence changes of precore and core promoter regions in HBeAg-positive chronic hepatitis B patients with and without HBeAg clearance in lamivudine therapyChien-Hung Chen, Chuan-Mo Lee, Sheng-Nan Lu, et al.
European Journal of Clinical Investigation|December 1, 2010
Anti-interleukin-6 receptor antibody inhibits the progression in human colon carcinoma cellsChih-Ping Hsu, Yung-Liang Chen, Chiu-Chen Huang, et al.
Scientific Reports|July 17, 2019
Evaluating BRCA mutation risk predictive models in a Chinese cohort in TaiwanFei-Hung Hung, Yong Alison Wang, Jhih-Wei Jian, et al.
World Journal of Surgery|September 28, 2019
The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary ResectionChun-Yu Lin, Chih-Che Lin, Chih-Chi Wang, et al.
The American Journal of the Medical Sciences|June 1, 2025
Overall survival was inferior in octogenarians with early-stage hepatocellular carcinoma undergoing percutaneous radiofrequency ablationYi-Hao Yen, Kwong-Ming Kee, Chao-Hung Hung, et al.
International Journal of Molecular Sciences|January 13, 2019
Efficacy of Azatyrosine-Phenylbutyric Hydroxamides, a Histone Deacetylase Inhibitor, on Chemotherapy-Induced Gastrointestinal MucositisPo-Lin Liao, Shih-Hsuan Huang, Chien-Hung Hung, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 4, 2020
Incidence and Factors Associated With HBV Relapse After Cessation of Entecavir or Tenofovir in Patients With HBsAg Below 100 IU/mLTzu-Ning Tseng, Tsung-Hui Hu, Jing-Houng Wang, et al.
Hepatology International|July 24, 2015
Combining the HBsAg decline and HBV DNA levels predicts clinical outcomes in patients with spontaneous HBeAg seroconversionShih-Cheng Yang, Sheng-Nan Lu, Chuan-Mo Lee, et al.
Pageof 57

Showing results (311-320 of 563) with videos related to

Sort By:
Pageof 57
Rheumatology International|April 14, 2009
IkBα promoter polymorphisms in patients with ankylosing spondylitisYu-Hung Hung, Tsan-Teng Ou, Chia-Hui Lin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 3, 2016
Liver stiffness-based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapyJing-Houng Wang, Yi-Hao Yen, Chih-Chien Yao, et al.
Journal of Hepatology|November 22, 2005
Comparison of sequence changes of precore and core promoter regions in HBeAg-positive chronic hepatitis B patients with and without HBeAg clearance in lamivudine therapyChien-Hung Chen, Chuan-Mo Lee, Sheng-Nan Lu, et al.
European Journal of Clinical Investigation|December 1, 2010
Anti-interleukin-6 receptor antibody inhibits the progression in human colon carcinoma cellsChih-Ping Hsu, Yung-Liang Chen, Chiu-Chen Huang, et al.
Scientific Reports|July 17, 2019
Evaluating BRCA mutation risk predictive models in a Chinese cohort in TaiwanFei-Hung Hung, Yong Alison Wang, Jhih-Wei Jian, et al.
World Journal of Surgery|September 28, 2019
The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary ResectionChun-Yu Lin, Chih-Che Lin, Chih-Chi Wang, et al.
The American Journal of the Medical Sciences|June 1, 2025
Overall survival was inferior in octogenarians with early-stage hepatocellular carcinoma undergoing percutaneous radiofrequency ablationYi-Hao Yen, Kwong-Ming Kee, Chao-Hung Hung, et al.
International Journal of Molecular Sciences|January 13, 2019
Efficacy of Azatyrosine-Phenylbutyric Hydroxamides, a Histone Deacetylase Inhibitor, on Chemotherapy-Induced Gastrointestinal MucositisPo-Lin Liao, Shih-Hsuan Huang, Chien-Hung Hung, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 4, 2020
Incidence and Factors Associated With HBV Relapse After Cessation of Entecavir or Tenofovir in Patients With HBsAg Below 100 IU/mLTzu-Ning Tseng, Tsung-Hui Hu, Jing-Houng Wang, et al.
Hepatology International|July 24, 2015
Combining the HBsAg decline and HBV DNA levels predicts clinical outcomes in patients with spontaneous HBeAg seroconversionShih-Cheng Yang, Sheng-Nan Lu, Chuan-Mo Lee, et al.
Pageof 57